# Palonosetron Associated to Aprepitant in Prophylaxis of PONV

> **NCT02431286** · PHASE4 · UNKNOWN · sponsor: **Instituto do Cancer do Estado de São Paulo** · enrollment: 90 (estimated)

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** Aprepitant
- **DRUG:** Placebo
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT02431286
- **Lead sponsor:** Instituto do Cancer do Estado de São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2015-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02431286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02431286, "Palonosetron Associated to Aprepitant in Prophylaxis of PONV". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02431286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*